Grazia Aleppo, MD
Enriched profileProfessor of Medicine, Division of Endocrinology, Metabolism and Molecular Medicine; Associate Chief for Clinical Affairs · Northwestern University Feinberg School of Medicine
Grazia Aleppo is Professor of Medicine, Division of Endocrinology, Metabolism and Molecular Medicine; Associate Chief for Clinical Affairs at Northwestern University Feinberg School of Medicine. OpenAlex indexes 289 publications with 25,632 citations (h-index 74); ClinicalTrials.gov lists 7 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.
Data verified 25 Aug 2026
Overview
Updated 14 Oct 2026
Grazia Aleppo, MD, is Professor of Medicine, Division of Endocrinology, Metabolism and Molecular Medicine at Northwestern University Feinberg School of Medicine. The public record shows 289 publications with 25,632 citations (h-index 74), centered on Diabetes Management and Research, Diabetes Treatment and Management, Diabetes and associated disorders. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 13 companies.
- Most recent indexed publication: 2026 · Journal of diabetes science and technology
- Top research focus: Diabetes Management and Research
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 13 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 39 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 158.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study
Sponsor: Indiana University
- Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
Sponsor: Insulet Corporation
- Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
Sponsor: Insulet Corporation
Industry payments
Updated 14 Oct 2026
13 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Dexcom, Inc.Program year20259 payments$15,056openpaymentsdata.cms.gov ↗
- Insulet CorporationProgram year202513 payments$10,104openpaymentsdata.cms.gov ↗
- Eli Lilly and CompanyProgram year20252 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
72.1%Insulin Analog35.8%Lantus Solostar30%Humalog Kwikpen U-10013%Novolog Flexpen10%Humalog9%Basaglar Kwikpen U-1009%Tresiba Flextouch U-1007%Fiasp Flextouch4%Novolog4%Humalog Kwikpen U-2003%Insulin Lispro Kwikpen U-1003%Admelog Solostar3%Tresiba Flextouch U-2003%Lantus2%Insulin Lispro2%Part D<11 patientsGLP-1 receptor agonist13.6%Ozempic49%Mounjaro34%Trulicity17%Part D≥38 patients+ 5 more classes in this area
Hormonal (systemic)
16%l-Thyroxine14.5%Levothyroxine Sodium74%Synthroid26%Part D≥61 patientsAntihypoglycemic Agent0.8%Gvoke Hypopen 2-Pack100%Part D≥11 patients+ 1 more class in this area
Cardiovascular
9.6%Statin6.5%Atorvastatin Calcium63%Rosuvastatin Calcium37%Part D≥30 patientsACE inhibitor1%Lisinopril100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 14 Oct 2026
40 congress contributions (2018–2026) across AACE, ADA, ENDO per OpenAlex. The most recent:
- 1068-OR: Multicenter, Randomized Trial of a Next-Generation Algorithm for Omnipod in Individuals with Type 1 or Type 2 Diabetes: The STRIVE Trial
ADA Scientific Sessions
ADA2026Co-authorOral - 1147-OR: Performance of a Next-Generation Algorithm for Omnipod in Adolescents and Adults with Type 1 Diabetes: Findings from the STRIVE Randomized Trial
ADA Scientific Sessions
ADA2026Co-authorOral
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Integrating the Glycemia Risk Index Into Clinical Practice and Research: A Consensus Report.
Journal of diabetes science and technology
Article2026 - Older Adults Benefit From Virtual Support for Continuous Glucose Monitor Use But Require Longer Visits.
Journal of diabetes science and technology
Article2026 - Addressing the Diabetes Tsunami Requires Expanded Access to Diabetes Technologies.
Journal of diabetes science and technology
Article2025 - A Randomized Trial Comparing Inhaled Insulin Plus Basal Insulin Versus Usual Care in Adults With Type 1 Diabetes.
Diabetes care
Clinical Trial2025
Most-cited works
by citation count (OpenAlex)Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/grazia-aleppo-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/grazia-aleppo-6b764347
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - LinkedIn
linkedin.com/in/grazia-aleppo-kacmarek-2a75a1241
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Grazia-Aleppo-2
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Instagram
instagram.com/reel/C8pmG0Ot8TK
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - Other
breakthroughsforphysicians.nm.org/endocrinology-clinical-podcast-expanding-the-role-of-cgm-in-type-2-diabetes-insights-from-grazia-aleppo-md.html
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →breakthroughsforphysicians.nm.org ↗ - Other
breakthroughsforphysicians.nm.org/endocrinology-research-podcast-grazia-aleppo-md-discusses-inhale-3-trial-and-diabetes-technology-updates.html
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →breakthroughsforphysicians.nm.org ↗ - Other
omnipod.com/hcp/clinical-resources/podcast/ep024
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →omnipod.com ↗ - X / Twitter
x.com/NMEndocrinology/status/1895229494320939471
- X / Twitter
x.com/NMEndocrinology/status/1917438282473807981
- X / Twitter
x.com/TheEndoSociety/status/1993033550875312294
- YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
University of Catania School of Medicine (Catania, Italy), graduated magna cum laude
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cardiometabolichealth.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pro.aace.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pro.aace.com ↗
- Endocrinology fellowship
University of Illinois at Chicago
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Editorial & leadership roles
journal and society appointments- Chair
Endocrine Society Clinical Affairs Core Committee
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pro.aace.com ↗ - Associate Editor
Diabetes Technology and Therapeutics
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hcplive.com ↗ - Editorial Board member
BMJ Open Diabetes Research & Care
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hcplive.com ↗ - Member
ADA Standards of Care guideline writing committee
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pro.aace.com ↗ - Protocol Chair
REPLACE-BG clinical trial (led to CMS coverage of CGM therapy for Medicare beneficiaries)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hcplive.com ↗
Secondary affiliations
appointments beyond the home institution- Center for Diabetes and Metabolism
Northwestern University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →feinberg.northwestern.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →feinberg.northwestern.edu ↗
- Medical Director
Northwestern Medicine Diabetes Training and Education Program
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pro.aace.com ↗
Media & interviews
press, podcasts and appearances- Northwestern Medicine "Breakthroughs for Physicians" endocrinology research podcast
ADA 2024 Highlights: INHALE-3 Trial and Diabetes Technology Updates
2024verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →breakthroughsforphysicians.nm.org ↗ - Endocrine Society "Endocrine Feedback Loop" podcast
EFL023: CGM Metrics and Diabetes Complications
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endocrine.org ↗ - "Diabetes Dialogue: Technology, Therapeutics & Real-World Perspectives" podcast
INHALE-3 and Diabetes Tech Updates episode, HCPLive
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →t1dexchange.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Clyde Yancy, MD
Northwestern University Feinberg School of Medicine
Martin Tallman, MD
Northwestern University Feinberg School of Medicine
Al Benson, MD
Northwestern University Feinberg School of Medicine
Sanjiv Shah, MD
Northwestern University Feinberg School of Medicine
Eric Van Cutsem, MD, PhD
University Hospitals Leuven (UZ Leuven)
Josep Tabernero, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Charles Fuchs, MD, MPH
Tubulis GmbH